[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:htlv-1-infection":3},{"name":4,"total":5,"recruiting":5,"trials":6},"HTLV-1 Infection",5,[7,15,22,28,35],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04799288","Teriflunomide in HTLV-1 Associated Myelopathy\u002FTropical Spastic Paraparesis",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:28.327680Z","2026-05-05T02:43:28.205393Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06698003","A Study of Mogamulizumab to Prevent Adult T-cell Leukemia\u002FLymphoma in People With HTLV-1",[19],"Phase 2","2026-08-26T02:18:36.226508Z","2026-05-05T02:43:27.103944Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT00001778","Evaluation of Patients With HAM\u002FTSP",[],"2026-08-26T02:16:06.684983Z","2026-05-13T02:55:06.027497Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT04301076","Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)",[32],"Phase 1","2026-08-26T02:16:08.402952Z","2026-07-19T19:36:05.132850Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT00006518","Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.028653Z"]